Review of ongoing initiatives to improve prescribing efficiency in China; Angiotensin receptor blockers as a case history

Keyphrases

• China 100%
• Angiotensin Receptor Blockers 100%
• Moderate Growth 33%
• Europe 33%
• Fixed-dose Combination 33%
• European Countries 33%
• Price Reduction 33%
• Physician Prescribing Patterns 33%
• Pharmaceutical Expenditure 33%
• Prescribing Quality 33%
• Total Expenditure 33%
• Drug Pricing 33%
• Pricing Regulations 33%
• Large Hospital 33%
• International Non-proprietary Name 33%
• Low Use 33%
• Perverse Incentives 33%
• Chongqing 33%
• Telmisartan 33%
• European Practice 33%
• Quality Incentive 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin Receptor Antagonist 100%
• Retrospective Study 33%
• Telmisartan 33%

Nursing and Health Professions

• Angiotensin Receptor Antagonist 100%
• Telmisartan 33%
• Observational Methodology 33%